{Reference Type}: Editorial
{Title}: Dermatologic immune-related adverse events to checkpoint inhibitors in cancer.
{Author}: Shah NJ;Lacouture ME;
{Journal}: J Allergy Clin Immunol
{Volume}: 151
{Issue}: 2
{Year}: 02 2023
{Factor}: 14.29
{DOI}: 10.1016/j.jaci.2022.11.015
{Abstract}: